CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −74 | $595.20 | $44K | 10,520 |
| 2025-12-02 | Dier Mardi EVP and CFO | Sale 10b5-1 | −80 | $596.19 | $48K | 10,440 |
| 2025-12-02 | Dier Mardi EVP and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,173 | 9,180 | ||
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale 10b5-1 | −894 | $550.97 | $493K | 11,096 |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale 10b5-1 | −144 | $547.27 | $79K | 10,952 |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale 10b5-1 | −120 | $548.71 | $66K | 10,832 |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale 10b5-1 | −40 | $549.34 | $22K | 10,792 |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale 10b5-1 | −200 | $552.38 | $110K | 10,592 |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale 10b5-1 | −40 | $553.23 | $22K | 10,552 |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale 10b5-1 | −120 | $556.04 | $67K | 10,432 |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale 10b5-1 | −200 | $559.60 | $112K | 10,232 |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale 10b5-1 | −80 | $560.62 | $45K | 10,152 |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale 10b5-1 | −40 | $563.21 | $23K | 10,112 |
| 2025-11-21 | Huntsman Carole Chief Commercial Officer | Sale 10b5-1 | −80 | $564.57 | $45K | 10,032 |
| 2025-11-13 | Levy Richard S Director | Option exercise 10b5-1 | +2,500 | $7.36 | $18K | 23,697 |
| 2025-11-13 | Levy Richard S Director | Option exercise 10b5-1 | +6,000 | $16.46 | $99K | 29,697 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −146 | $514.67 | $75K | 29,551 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −919 | $515.64 | $474K | 28,632 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −645 | $517.51 | $334K | 27,987 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −835 | $518.53 | $433K | 27,152 |
Page 12 of 82 · 1,629 trades